Biotech entity

Kyoto University

organization

All 1 tracked stories fall under one category: fda-approval. Kyoto University is most often covered alongside Jun Takahashi, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Kyoto University, all published on March 6, 2026.

Last mentioned: Mar 6, 2026

Entity pulse

Recent coverage · Kyoto University

1 story
9 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Kyoto University

All 1 tracked stories fall under one category: fda-approval. Kyoto University is most often covered alongside Jun Takahashi, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Kyoto University, all published on March 6, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Kyoto University. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Regulatory Approval

    Japan grants official approval for commercial use of the therapy.

  2. Trial Completion

    Phase II data confirms safety and efficacy in human subjects.

  3. First Human Trial

    Kyoto University begins the world's first iPS cell transplant for Parkinson's.

  4. Nobel Prize

    Yamanaka wins the Nobel Prize in Medicine for his iPS cell research.

  5. iPS Discovery

    Shinya Yamanaka discovers how to create induced pluripotent stem cells.

Stories mentioning Kyoto University 1

FDA Actions Strongly positive

Japan Grants World-First Approval for iPS Stem-Cell Parkinson's Therapy

Japan has officially approved the world's first stem-cell-based treatment for Parkinson's disease, utilizing induced pluripotent stem (iPS) cells. The therapy, developed by Kyoto University and Sumitomo Pharma, marks a historic shift from symptom management to regenerative repair for neurodegenerative disorders.

3 sources

Kyoto University is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.